Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [Elsevier BV]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
G1997完成签到,获得积分10
1秒前
老顽童完成签到 ,获得积分10
1秒前
学术小白two完成签到,获得积分10
1秒前
榴莲受众完成签到,获得积分10
1秒前
xiong完成签到,获得积分10
2秒前
姬昌发布了新的文献求助10
2秒前
2秒前
淡淡的方盒完成签到,获得积分10
3秒前
3秒前
3秒前
包容元芹发布了新的文献求助10
3秒前
上官天宇应助tiffany采纳,获得10
3秒前
4秒前
从容的盼晴完成签到,获得积分10
5秒前
Kxxxx完成签到,获得积分20
5秒前
大力的保温杯完成签到 ,获得积分10
5秒前
寒冷的语蝶完成签到 ,获得积分10
5秒前
ding应助白泽采纳,获得10
5秒前
Who1990完成签到,获得积分10
5秒前
爆米花应助G1997采纳,获得10
6秒前
LSMY完成签到,获得积分10
6秒前
朱摩玑完成签到,获得积分10
6秒前
nie发布了新的文献求助10
7秒前
健忘曼彤完成签到,获得积分10
7秒前
kjh完成签到,获得积分10
7秒前
owen3710发布了新的文献求助10
7秒前
留无影完成签到,获得积分10
7秒前
xsddc关注了科研通微信公众号
8秒前
LW90完成签到,获得积分10
8秒前
Kxxxx发布了新的文献求助10
8秒前
9秒前
是小豆子呀完成签到,获得积分10
9秒前
kazewwk完成签到,获得积分10
9秒前
10秒前
潇洒皮带完成签到,获得积分10
10秒前
xuan21完成签到,获得积分10
10秒前
Arreboled完成签到,获得积分10
10秒前
为什么不能免费完成签到 ,获得积分10
12秒前
不安钢铁侠完成签到,获得积分10
12秒前
淡淡灵凡应助科研通管家采纳,获得10
12秒前
高分求助中
Markov Chain Monte Carlo 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Common Foundations of American and East Asian Modernisation: From Alexander Hamilton to Junichero Koizumi 5000
Pediatric Dermoscopy Trichoscopy & Onychoscopy 1000
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
Data book on fatigue strength of metallic materials 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7566185
求助须知:如何正确求助?哪些是违规求助? 9146407
关于积分的说明 19556871
捐赠科研通 7152446
什么是DOI,文献DOI怎么找? 3262596
关于科研通互助平台的介绍 2428866
邀请新用户注册赠送积分活动 2252478